These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8674056)

  • 1. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
    Beck WT; Grogan TM; Willman CL; Cordon-Cardo C; Parham DM; Kuttesch JF; Andreeff M; Bates SE; Berard CW; Boyett JM; Brophy NA; Broxterman HJ; Chan HS; Dalton WS; Dietel M; Fojo AT; Gascoyne RD; Head D; Houghton PJ; Srivastava DK; Lehnert M; Leith CP; Paietta E; Pavelic ZP; Weinstein R
    Cancer Res; 1996 Jul; 56(13):3010-20. PubMed ID: 8674056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoprotein.
    Lehne G; De Angelis P; Clausen OP; Egeland T; Tsuruo T; Rugstad HE
    Cytometry; 1995 Jul; 20(3):228-37. PubMed ID: 7587708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
    Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP
    Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the role of P-glycoprotein expression in clinical trials: applying pharmacological principles and best methods for detection together with good clinical trials methodology.
    Ferry DR
    Int J Clin Pharmacol Ther; 1998 Jan; 36(1):29-40. PubMed ID: 9476146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.
    Eid H; Géczi L; Mágori A; Bodrogi I; Institoris E; Bak M
    Anticancer Res; 1998; 18(4C):3059-64. PubMed ID: 9713510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique human ovarian carcinoma cell line expressing CD34 in association with selection for multidrug resistance.
    Minderman H; Vanhoefer U; Toth K; Minderman MD; Rustum YM
    Cancer; 1996 Dec; 78(11):2427-36. PubMed ID: 8941015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDR1 gene expression in primary and advanced breast cancer.
    Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
    Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of new cellular lymphoma model expressing transgenic human MDR1.
    Findling-Kagan S; Sivan H; Ostrovsky O; Nagler A; Galski H
    Leuk Res; 2005 Apr; 29(4):407-14. PubMed ID: 15725475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
    Nooter K; Stoter G
    Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis.
    Müller MR; Lennartz K; Nowrousian MR; Dux R; Tsuruo T; Rajewsky MF; Seeber S
    Cytometry; 1994 Jan; 15(1):64-72. PubMed ID: 7512893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein expression in the squamous cell carcinoma of the tongue base.
    Rabkin D; Chhieng DC; Miller MB; Jennings T; Feustel P; Steiniger J; Parnes SM
    Laryngoscope; 1995 Dec; 105(12 Pt 1):1294-9. PubMed ID: 8523980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
    Ihnat MA; Nervi AM; Anthony SP; Kaltreider RC; Warren AJ; Pesce CA; Davis SA; Lariviere JP; Hamilton JW
    Oncol Res; 1999; 11(7):303-10. PubMed ID: 10757444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic drug-induced multidrug resistance P-glycoprotein overexpression in astrocytes cultured from rat brains.
    Lü Y; Yan Y; Wang XF
    Chin Med J (Engl); 2004 Nov; 117(11):1682-6. PubMed ID: 15569486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer.
    Krasznai ZT; Friedländer E; Nagy A; Szabó G; Vereb G; Goda K; Hernádi Z
    Anticancer Res; 2005; 25(2A):1187-92. PubMed ID: 15868961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.